The assets of the present paper are that it evaluates both the PD-L1 expression and immune infiltrate in GIST, it brings to attention a more accurate method of scoring PD-L1 (i.e., CPS) and it analyses different tumor risk classes. Here, CD274 is linked to neoplasm.